ITOS
Iteos Therapeutics, Inc.
CFO Matthew Gall sold $232K of Iteos Therapeutics, Inc.
Sold$232,250
$46.45Price
5,000Shares
−26%Stake
What ITOS did after the filing
- The stock from Wed, Dec 29 open, $48.05
- −26.1%
- S&P 500, same days
- −5.8%
Measured over 30 trading days, to the Feb 10 close.
Traded Mon, Dec 27. Filed Tue, Dec 28, 8:58 PM ET, after the close. Returns use the Dec 29 open and the Feb 10 close. Not investment advice.